Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Scalpel Versus Diathermy for Transverse Abdominal Incision in First Elective Caesarean Section

N/AUnknownNCT05905861
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari84 enrolled

Overview

The objective of this study will be to compare two methods of skin incisions during the first caesarean section (CS), that is scalpel and diathermy, assessing differences in blood loss during incision, incisional time, total surgery time, post-operative pain, wound healing, complications, and cosmetic outcomes.

The scalpel has been historically used as the primary cutting tool during caesarean section (CS). However, advancements in surgical devices have introduced alternatives, such as the option to make a diathermic cut using electrosurgical units. General surgeons have extensively demonstrated the advantages of diathermy over the scalpel for abdominal wall incisions, including faster opening time, reduced incisional blood loss, decreased post-operative pain, and a comparable wound complication rate. In obstetrics, there is a scarcity of evidence in this regard, and no consensus or guidelines have been established regarding the optimal method for making a transverse abdominal incision during the first elective CS. Currently, the choice between using a scalpel or diathermy remains at discretion of the obstetric surgeon. The objective of this study will be to compare both methods of skin incisions during the first CS, assessing differences in blood loss during incision, incisional time, total surgery time, post-operative pain, wound healing, complications, and cosmetic outcomes.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

DOUBLE

Enrollment

84

Conditions

Cesarean SectionIntraoperative Blood LossPostoperative PainWound Heal

Interventions

Skin incision with scalpel.PROCEDURE

A Pfannenstiel skin incision will be performed using a scalpel, extending through the subcutaneous tissue and rectus sheath. After separation of rectus muscles, peritoneum will be visualized and opened. Optimal hemostasis will be achieved by applying pressure to skin blood vessels and ligating any subcutaneous bleeding. Group A: skin incision with a scalpel.

Skin incision with a diathermy.PROCEDURE

A Pfannenstiel skin incision will be made using a scalpel. Subsequently, a diathermy pen electrode will be employed for the dissection of deeper tissues. Optimal hemostasis will be achieved by using the same blade pen electrode, set to coagulation mode. Group B: skin incision with diathermy.

Eligibility

Sex: FEMALEMin age: 18 YearsHealthy volunteers:
Medical Language ↔ Plain English
Inclusion Criteria: 1. Women without a history of previous cesarean section or other abdominal surgery 2. Age greater then 18 years (only adult patients) 3. Body Mass Index (BMI) between 18.5 and 29.9 kg/m2 4. Gestational age greater then 37 weeks (at term pregnancies) 5. No contraindications to spinal anesthesia 6. Indication to elective CS: extra-obstetrical reasons, failure of medical induction of labor, breech fetal presentation 7. Informed consent Exclusion Criteria: 1. Women refusing to participate in the study 2. Women undergoing urgency or emergency cesarean deliveries 3. Women with a history of previous cesarean section or abdominal surgery 4. Women with multifetal pregnancies 5. Necessity of general anesthesia 6. Use of anticoagulants 7. Patients needing a median longitudinal abdominal section 8. Patients with pacemakers 9. Allergy to cephalosporins 10. Any medical disorder that can affect wound healing as diabetes, hypertension, hepatic or renal diseases, chronic anemia, chronic skin conditions, congenital or acquired bleeding diathesis.

Locations (1)

Azienda Ospedaliero-Universitaria "Consorziale Policlinico"

Bari, Italy

Outcomes

Primary Outcomes

Incision blood loss

This will be calculated by weighing the gauze pre and postoperatively (1mg = 1ml) after complete hemostasis will be achieved.

Time frame: During surgery

Secondary Outcomes

Incision time

We will compare incisional time by using a digital clock. The incisional time will be established as follows: when skin incision will be made, the surgeon will verbally announce "start ". Once the parietal peritoneum will be opened, the surgeon will announce "stop". The incision time will be calculated as the difference between "start" and "stop" times.

Time frame: During surgery

Total surgery time

Total surgery time will be the time between the start of the skin incision and the completion of the skin suture.

Time frame: During surgery

Post-operative pain assessed by VAS

Post-operative pain will be evaluated for each participant at 1, 4, 8, 16, 24, 48, 72 hours postoperatively, by using the Visual Analog Scale (VAS). The VAS consists of a 10 cm long horizontal line with its extremes marked as 'no pain' (0) and 'worst pain imaginable' (10).

Time frame: During the first three days after surgery

Wound complications

Will include edema, seroma, hematoma, dehiscence, and infection. The wound will be evaluated 24h and 72h after surgery, before patients discharge. Then, outpatient wound evaluation will be made 7 and 30 days after surgery.

Time frame: During the first month after surgery

Cosmetic wound evaluation assessed by POSAS

The cosmetic aspect of the wound will be evaluated outpatient 30 days after surgery by using the Patient and Observer Scar Assessment Scale (POSAS), that is a questionnaire that was developed to assess scar quality. It consists of two separate six-item scales (Observer Scale and Patient Scale), both of which are scored on a 10-point rating scale (1 = best result; 10 = worst result).

Time frame: One month after surgery

Central Contacts

Amerigo Vitagliano, MD, PhD

CONTACT

0805593321amerigo.vitagliano@gmail.com

Amerigo Vitagliano

CONTACT

0805593321amerigo.vitagliano@gmail.com
Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.